You are here Home Vaccines Vaccines Fluzone High-Dose Quadrivalent Details for Fluzone High-Dose Quadrivalent vaccine and its components. Listen Print Share Twitter Facebook Email Recently added This page was added on 02 May 2022. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor Sanofi-Aventis Australia Administration route Intramuscular injection Vaccine group Adults aged ≥60 years only Description: Registered for use in people aged ≥60 years.Quadrivalent inactivated influenza vaccine, split virion.Each 0.7 mL monodose pre-filled syringe contains:60 µg haemagglutinin of each of the 4 recommended influenza virus strains sodium chloride dibasic sodium phosphate monobasic sodium phosphate octoxinol-9 water May contain traces of:≤ 140 µg formaldehyde ≤ 1 µg ovalbumin For Product Information and Consumer Medicine Information about Fluzone High-Dose Quadrivalent visit the Therapeutic Goods Administration website. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Related diseases Influenza (flu) Page history Last updated 21 April 2022 Last reviewed 21 April 2022 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank